
    
      This is a pilot study having a randomized, double-blind parallel group comparison of two
      iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients
      enrolled must have eGFR greater than or equal to 30 mL/min and less than or equal to 59
      mL/min. Statistical summaries will be presented to analyze the various lab tests results for
      the two groups.
    
  